Head-to-head comparisons of medication uses, side effects, warnings, and more.
Kesimpta (ofatumumab)
Ocrevus (ocrelizumab)
Kesimpta (ofatumumab)
Ocrevus (ocrelizumab)
Summary of Kesimpta vs. Ocrevus
Summary for Monoclonal antibody
Prescription only
Kesimpta (ofatumumab) is an injectable medication for adults with relapsing forms of multiple sclerosis (MS). It works as a monoclonal antibody to help lessen MS flare-ups that come and go. Kesimpta (ofatumumab) is injected under the skin. You can use the Kesimpta prefilled syringes or Sensoready Pens to inject. After the first 3 weekly injections, you inject the medication once a month. Some common side effects include a higher risk of infections, pain or swelling at the injection site, and headache.
Summary for Monoclonal antibody
Prescription only
Ocrevus (ocrelizumab) is used to treat multiple sclerosis (MS) in adults. It's a type of medication called a monoclonal antibody. It's given as an infusion through the vein every 6 months at a medical center or clinic. A trained healthcare professional will help give Ocrevus (ocrelizumab) to you. Side effects can include a higher risk of infections and infusion reactions.